Unknown

Dataset Information

Oral transforming growth factor-beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity.


ABSTRACT:

SUBMITTER: Choi SH 

PROVIDER: S-EPMC11337916 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature